BIOGEN INC. - COMMON S

Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer’s Disease to be Authorized in the European Union

15 أبريل 2025 19:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

09 أبريل 2025 09:45:15 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

08 أبريل 2025 13:06:04 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

07 أبريل 2025 09:45:03 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

04 أبريل 2025 09:47:36 بحسب NetDania Notify

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

02 أبريل 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square

24 مارس 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Biogen Initiates Phase 3 Study of Felzartamab for the Treatment of Late Antibody-Mediated Rejection (AMR) in Kidney Transplant Patients

11 مارس 2025 07:30:00 بحسب Nasdaq GlobeNewswire

Biogen and Stoke Therapeutics Enter into Collaboration to Develop and Commercialize Zorevunersen for the Treatment of Dravet Syndrome, a Rare Genetic Epilepsy Associated with Refractory Seizures and Neurodevelopmental Impairments

18 فبراير 2025 08:00:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

12 فبراير 2025 09:45:10 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

11 فبراير 2025 11:11:08 بحسب NetDania Notify

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

31 يناير 2025 06:30:52 بحسب Nasdaq GlobeNewswire

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

26 يناير 2025 18:33:52 بحسب Nasdaq GlobeNewswire

FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA

23 يناير 2025 07:30:54 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

22 يناير 2025 09:46:19 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

16 يناير 2025 09:45:18 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

15 يناير 2025 11:45:04 بحسب NetDania Notify

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

14 يناير 2025 12:44:54 بحسب NetDania Notify

FDA Accepts LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease

13 يناير 2025 19:05:00 بحسب Nasdaq GlobeNewswire

NetDania - New 12 months Low: BIOGEN INC. - COMMON STOCK

20 ديسمبر 2024 09:45:32 بحسب NetDania Notify